IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2019i1p210-d302628.html
   My bibliography  Save this article

Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis

Author

Listed:
  • Ya-Yen Yu

    (Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
    Department of Clinical Laboratory, Changhua Hospital, Changhua 513, Taiwan)

  • Shih-Ming Tsao

    (Division of Chest, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 402, Taiwan
    Institute of Biochemistry, Microbiology and Immunology, Chung Shan Medical University, Taichung 402, Taiwan)

  • Wen-Ta Yang

    (Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung 403, Taiwan)

  • Wei-Chang Huang

    (Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 407, Taiwan
    Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli 356, Taiwan
    Department of Life Sciences, National Chung Hsing University, Taichung 402, Taiwan
    Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung 407, Taiwan)

  • Ching-Hsiung Lin

    (Division of Chest, Changhua Christian Hospital, Changhua 500, Taiwan)

  • Wei-Wen Chen

    (Department of Health, Pulmonary and Critical Care Unit, Changhua Hospital, Changhua 500, Taiwan)

  • Shun-Fa Yang

    (Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
    Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan)

  • Hui-Ling Chiou

    (School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 402, Taiwan
    Department of Clinical Laboratory, Chung Shan Medical University Hospital, Taichung 402, Taiwan)

  • Yi-Wen Huang

    (Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan
    Department of Health, Pulmonary and Critical Care Unit, Changhua Hospital, Changhua 500, Taiwan)

Abstract

Weekly rifapentine and isoniazid therapy (3HP) is the most frequent treatment for latent tuberculosis infection (LTBI). However, the association between major adverse drug reactions (ADRs) and drug metabolic enzyme single-nucleotide polymorphisms (SNPs) remains unclear. In this study, 377 participants who received the 3HP regimen were recruited and examined for genotyping of CYP5A6, CYP2B6, CYP2C19, CYP2E1, and NAT2 SNPs. In our study, 184 participants (48.4%) developed ADRs. Moreover, CYP2C19 rs4986893 (TT vs. CC+CT, odds ratio [OR] [95% CI]: 2.231 [1.015–4.906]), CYP2E1 rs2070676 (CC vs. CG+GG, OR [95% CI]: 1.563 [1.022–2.389]), and CYP2E1 rs2515641 (CC vs. CT+TT, OR [95% CI]: 1.903 [1.250–2.898]) were associated with ADR development. In conclusion, CYP2C19 and CYP2E1 SNPs may provide useful information regarding ADRs in LTBI patients receiving the 3HP regimen.

Suggested Citation

  • Ya-Yen Yu & Shih-Ming Tsao & Wen-Ta Yang & Wei-Chang Huang & Ching-Hsiung Lin & Wei-Wen Chen & Shun-Fa Yang & Hui-Ling Chiou & Yi-Wen Huang, 2019. "Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis," IJERPH, MDPI, vol. 17(1), pages 1-9, December.
    • Handle: RePEc:gam:jijerp:v:17:y:2019:i:1:p:210-:d:302628
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/1/210/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/17/1/210/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Mary V. Relling & William E. Evans, 2015. "Pharmacogenomics in the clinic," Nature, Nature, vol. 526(7573), pages 343-350, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. M Dahmani Fathallah, 2017. "Genomics, Gene Editing and Biologics: The Bolsters of the New Medical Paradigm," Current Trends in Biomedical Engineering & Biosciences, Juniper Publishers Inc., vol. 6(4), pages 75-78, July.
    2. Perry, Seth W & Allison, Stephen & Bastiampillai, Tarun & Wong, Ma-Li & Licinio, Julio & Sharfstein, Steven S. & Wilcox, Holly C., 2019. "Rising US Suicides: Achieving Health Equity," OSF Preprints m5q64, Center for Open Science.
    3. Degtiar, Irina, 2017. "A review of international coverage and pricing strategies for personalized medicine and orphan drugs," Health Policy, Elsevier, vol. 121(12), pages 1240-1248.
    4. Ligia Traldi Macedo & Vinicius Eduardo Ferrari & Juliana Carron & Ericka Francislaine Dias Costa & Leisa Lopes-Aguiar & Gustavo Jacob Lourenço & Carmen Silvia Passos Lima, 2019. "Cost-minimization analysis of GSTP1c.313A>G genotyping for the prevention of cisplatin-induced nausea and vomiting: A Bayesian inference approach," PLOS ONE, Public Library of Science, vol. 14(3), pages 1-13, March.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2019:i:1:p:210-:d:302628. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.